RADCOM Ltd. — FY 2011 Form 20-F
Reporting period: Fiscal year ended December 31, 2011. This is an annual report, not a standalone Q4 filing; the supplied filing text does not provide a complete Q4 income statement. Amounts below are U.S. dollars unless noted.
Business context
RADCOM provides service-assurance and network-monitoring solutions to communications service providers and equipment vendors. Its principal product family, Omni-Q, generated most revenue. The company reported one operating segment and focused on 3G/4G, LTE, IMS, VoIP and emerging markets.
Financial performance and position
| Metric | FY 2011 | FY 2010 |
|---|---|---|
| Revenue | $21.987 million | $19.173 million |
| Gross profit | $15.307 million; 69.6% margin | $12.687 million; 66.2% margin |
| Operating income (loss) | $(1.520) million | $1.292 million |
| Net income (loss) | $(1.904) million | $0.570 million |
| Operating cash flow | $(3.350) million | $(2.498) million |
| Cash and cash equivalents at year-end | $2.901 million | $5.744 million |
| Working capital | $10.670 million | $11.144 million |
| Total assets | $21.345 million | $21.386 million |
| Shareholders’ equity | $10.392 million | $10.903 million |
Year-end current assets were $18.370 million and current liabilities $7.700 million. The filing reports no outstanding venture loan at year-end; the Plenus loan was repaid in 2010. FY 2011 investing cash outflow was $0.103 million and financing cash inflow was $0.767 million, primarily from option and warrant exercises.
Material changes versus FY 2010
- Revenue rose 15%, led by Omni-Q sales, which increased to $20.949 million from $17.489 million. Brazil contributed $5.234 million, versus $4.107 million in 2010.
- Gross margin improved to 69.6% from 66.2%, but operating performance swung from income to a loss as operating expenses increased 47% to $16.827 million.
- Management attributed higher R&D and sales and marketing costs to investment in personnel, international offices and sales capabilities, particularly in Brazil. R&D staffing increased to 56 from 44.
- Operating cash use increased, and cash declined by $2.843 million. Inventory increased to $6.590 million from $3.949 million; $4.680 million related to products delivered to customers but not yet eligible for revenue recognition. Trade receivables decreased to $5.389 million from $6.851 million.
- Share-based compensation expense rose to $0.823 million from $0.564 million, partly reflecting accelerated option vesting.
Outlook, risks and contingencies
- Management expected demand for service-assurance solutions to continue growing in 2012 and beyond, citing mobile-data traffic, LTE/IMS deployments and network expansion in emerging markets. It provided no specific revenue or earnings guidance.
- Management said existing capital resources and operating cash flows should cover expected liquidity needs through at least December 2012, based on backlog and market trends. It cautioned that weaker-than-projected sales or spending could require additional financing or reduced discretionary spending; continued operations depend substantially on executing those projections.
- Large deals involve longer sales cycles, conditional payment terms and customer acceptance that can delay revenue recognition, typically by 6–12 months. Quarterly results can fluctuate materially; orders and revenue are generally seasonally strongest in Q4.
- The company reported a $28.6 million contingent obligation to Israel’s Office of the Chief Scientist (OCS), payable through royalties on qualifying sales. The OCS had alleged royalty-calculation differences for 1992–2009; RADCOM said it believed amounts were paid or accrued but could not assess the merits or quantify any additional exposure. BIRD Foundation contingent royalties were approximately $0.342 million.
- Other material risks include dependence on limited component suppliers and contract manufacturers, distributor and customer concentration, competition, foreign-exchange exposure, Israeli geopolitical and operating risks, and restrictions attached to government R&D grants. The seven largest distributors accounted for 43.9% of 2011 sales; no individual customer exceeded 10%.
- The filing reports no material legal proceedings. It identifies customer performance guarantees totaling $0.581 million and a further $0.026 million guarantee, with stated expirations in 2012–2013.
Investor verification priorities
- Review the audited statements and subsequent disclosures for cash burn, liquidity, working-capital requirements and financing needs after year-end.
- Verify how much of the $4.680 million of customer-held inventory subsequently met acceptance and revenue-recognition criteria, and assess collection timing and customer payment conditions.
- Track resolution of the OCS royalty review, including any revised royalty base, additional accrual or payment requirement.
- Assess whether expanded sales and R&D spending produces sustained revenue growth and operating profitability, and whether gross margins remain near the 2011 level.
- Check exposure to Brazil and other emerging markets, currency movements, distributor concentration and the availability of key components.